Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/ABBOTINDIA stock hub

NSE/ABBOTINDIA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ABBOTINDIAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

566.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ABBOTINDIA

In the news

Latest news · NSE/ABBOTINDIA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.7

P25 24.9P50 32.4P75 45.7

Trailing P/E37.2

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC71.7

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ABBOTINDIA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

INR

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	3,659
Employees Change	-155%
Employees Change Percent	-4.06
Enterprise value	INR 544.9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE358A01014
Last refreshed	2026-05-10
Market cap	INR 566.5B
Price	INR 26,850
Price currency	INR
Rev Per Employee	18,650,259.63x
Sector	Healthcare
Sic	2834
Symbol	nse/ABBOTINDIA
Website	https://www.abbott.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.69%
EV Earnings	35.75x
EV/EBIT	30.82x
EV/EBITDA	29.59x
EV/Sales	7.99x
Forward P/E	33.68x
P/B ratio	14.12x
P/E ratio	37.17x
P/S ratio	8.3x
PE Ratio10 Y	43.83x
PE Ratio3 Y	46.35x
PE Ratio5 Y	48.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.91%
EBITDA Margin	26.36%
Gross margin	46.41%
Gross Profit	INR 31.7B
Gross Profit Growth	13.74%
Gross Profit Growth Q	12.98%
Gross Profit Growth3 Y	10.24%
Gross Profit Growth5 Y	11.64%
Net Income	INR 15.2B
Net Income Growth	14.21%
Net Income Growth Q	4.21%
Net Income Growth Quarters	20%
Net Income Growth Years	14%
Net Income Growth3 Y	17.93%
Net Income Growth5 Y	18.61%
Pretax Margin	29.76%
Profit Margin	22.33%
Profit Per Employee	INR 4.2M
Profitable Years	21
Roa5y	16.55
Roe5y	31.81
ROIC	71.7
Roic5y	135.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.53%
Cagr15y	22.03%
Cagr1y	-10.29%
Cagr3y	7.32%
Cagr5y	12.72%
Div CAGR10	29.8%
Div CAGR3	13.48%
Div CAGR5	11.55%
EPS Growth	14.21
EPS Growth Q	4.21
EPS Growth Quarters	20
EPS Growth Years	14
EPS Growth3 Y	17.92
EPS Growth5 Y	18.61
Revenue Growth	9.31x
Revenue Growth Q	6.8x
Revenue Growth Quarters	34x
Revenue Growth Years	20x
Revenue Growth3 Y	9.03x
Revenue Growth5 Y	10.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 23.4B
Debt	INR 1.8B
Debt EBITDA	INR 0.1
Debt Equity	INR 0.05
Equity	INR 40.1B
Interest Coverage	95.89
Net Cash	INR 21.6B
Net Cash By Market Cap	INR 3.81
Net Cash Growth	106.65%
Net Debt EBITDA	INR -1.2
Net Debt Equity	INR -0.54
Tangible Book Value	INR 40.1B
Tangible Book Value Per Share	INR 1,885
WACC	4.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	15.85%
Dividend Growth Years	3%
Dividend per share	INR 475
Dividend Years	25
Dividend Yield	1.88%
Ex Div Date	2025-07-25
Last Dividend	INR 475
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	546.92%
1Y total return	-10.29%
200-day SMA	28,984.5
3Y total return	23.62%
50-day SMA	26,211.7
50-day SMA vs 200-day SMA	50under200
5Y total return	81.92%
All Time High	37,000
All Time High Change	-27.43%
All Time High Date	2025-06-27
All Time Low	697.1
All Time Low Change	3,751.67%
All Time Low Date	2010-02-01
ATR	521.7
Beta	-0.01
Ch YTD	-7.49
High	26,880
High52	37,000
High52 Date	2025-06-27
High52ch	-27.43%
Low	26,550
Low52	25,150
Low52 Date	2026-04-24
Low52ch	6.76%
Ma50ch	2.44%
Price vs 200-day SMA	-7.36%
RSI	64.68
RSI Monthly	47.55
RSI Weekly	44.65
Sharpe ratio	-0.64x
Sortino ratio	-0.69
Total Return	1.88%
Tr YTD	-7.49
Tr15y	1,882.55%
Tr1m	4.62%
Tr1w	5.65%
Tr3m	-1.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 17.7B
Operating Income Growth	15.87
Operating Income Growth Q	6.36
Operating Income Growth3 Y	15.15
Operating Income Growth5 Y	17.04
Operating margin	25.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,193,133%
Shares Insiders	0%
Shares Institutions	7.89%
Shares Qo Q	0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	15,122.35x
Bv Per Share	1,887.5
Ch10y	475.1
Ch15y	1,591.6
Ch1m	4.62
Ch1w	5.65
Ch1y	-11.52
Ch3m	-1.88
Ch3y	18.54
Ch5y	69.4
Ch6m	-6.72
Change	0.56%
Change From Open	0.04
Close	26,700
Days Gap	0.52
Depreciation Amortization	308,525,000
Dollar Volume	298,330,350
Earnings Date	2026-05-11
EBIT	INR 17.7B
EBITDA	INR 18B
EPS	INR 717
F Score	2
Fiscal Year End	March
Founded	1,910
Graham Number	5558.26923
Graham Upside	-79.3
Income Tax	INR 5.1B
Is Primary Listing	0
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Lynch Fair Value	INR 13,444
Lynch Upside	-49.93
Ma150	27,838.2
Ma150ch	-3.55%
Ma20	25,705
Ma20ch	4.45%
Next Earnings Date	2026-05-11
Open	26,840
Payment Date	2025-09-12
Position In Range	90.91
Price Date	2026-05-08
Price EBITDA	INR 31.49
Ptbv Ratio	14.14
Relative Volume	0.73x
Revenue	68,241,300,000x
Tax By Revenue	7.42x
Tax Rate	24.95%
Tr6m	-6.72%
Volume	11,111

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/ABBOTINDIA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$475 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.6%

3 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2025-07-25

Performance

NSE/ABBOTINDIA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ABBOTINDIA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.9%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

0.0%

Negative means the company is buying back shares.

Technical

NSE/ABBOTINDIA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.7

Neutral momentum band

Price vs 200-day MA

-7.4%

50/200-day relationship not available

Beta (5Y)

-0.01

Less volatile than the market

Sharpe ratio

-0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ABBOTINDIA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ABBOTINDIA stock rating?

nse/ABBOTINDIA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ABBOTINDIA analysis?

The full report lives at /stocks/nse/ABBOTINDIA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ABBOTINDIA?

The latest report frames nse/ABBOTINDIA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ABBOTINDIA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.